Xie Jiaoyang, Zhang Lixin, Ruan Yanping, Hao Xiaoyan, Wang Hairui, Zhang Ye, Han Jiancheng, Liu Tingting, He Yihua, Gu Xiaoyan
Echocardiography Medical Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
J Clin Ultrasound. 2025 Jul-Aug;53(6):1346-1366. doi: 10.1002/jcu.24006. Epub 2025 Apr 22.
This seven-year study investigates risk factors for long-term mortality in AMI patients with ventricular septal rupture (VSR) to enhance clinical management and outcomes.
We conducted a retrospective cohort study of 180 AMI patients with VSR from January 2016 to October 2023. We collected data on demographics, clinical features, treatments, and outcomes. Patients were divided into survival and death groups and further classified by treatment (surgical repair vs. medical management). Cox proportional hazards regression identified predictors of long-term mortality.
Median follow-up was 1028 days, with an overall mortality rate of 65.6%. The death group had a higher rate of medical management (83.1% vs. 35.5% in survivors). Long-term mortality rates were 33.3% for surgical repair and 81.7% for medical management. Independent predictors of poor outcomes included Killip Class 3-4, female gender, and advanced age. Surgical repair was a protective factor against mortality (HR 0.232). Killip Class 3-4 (HR 5.154) was a significant independent risk factor for long-term mortality among surgical patients. Killip Class 3-4 (HR, 3.268) and female gender (HR 2.548) were significant independent risk factors for long-term mortality among medical management patients.
Surgical repair significantly reduces long-term mortality compared to medical management in AMI patients with VSR. Killip Class 3-4 affects prognosis, emphasizing the need for tailored management strategies.
这项为期七年的研究调查了急性心肌梗死(AMI)合并室间隔破裂(VSR)患者长期死亡的危险因素,以加强临床管理并改善预后。
我们对2016年1月至2023年10月期间180例AMI合并VSR患者进行了回顾性队列研究。我们收集了人口统计学、临床特征、治疗方法及预后的数据。患者被分为生存组和死亡组,并根据治疗方法(手术修复与药物治疗)进一步分类。Cox比例风险回归分析确定了长期死亡的预测因素。
中位随访时间为1028天,总死亡率为65.6%。死亡组接受药物治疗的比例更高(83.1%,而存活组为35.5%)。手术修复组的长期死亡率为33.3%,药物治疗组为81.7%。不良预后的独立预测因素包括Killip分级3-4级、女性和高龄。手术修复是降低死亡率的保护因素(风险比[HR]为0.232)。Killip分级3-4级(HR为5.154)是手术患者长期死亡的重要独立危险因素。Killip分级3-4级(HR为3.268)和女性(HR为2.548)是药物治疗患者长期死亡的重要独立危险因素。
与药物治疗相比,手术修复可显著降低AMI合并VSR患者的长期死亡率。Killip分级3-4级影响预后,强调需要制定个性化的管理策略。